General discussion, page-1483

Then that simply continues the status quo, that is that Cannvalate's network and dominance will continue to have an effective monopoly.

Some will still seek out the low dose products if it helps them at all, might reduce a bit of pain who knows. But for anyone who wants medical effects they will have to continue to go through SAS, and the likes of Cannvalate.

On another note, anyone see ADN today? I know there a bunch of ADN mutual holders in this thread.
Another enormous flurry of options conversions leading into some decent news anns and boom they just hit ATH today at 10c.

I just have the feeling that IHL is about to join ADN and NVA reaaaaaal soon.